,title,source,link,date
20,"Nifty, Sensex May Try to Rise But the Trend is Down - Weekly ...",Moneylife,news.google.com/articles/CBMidGh0dHBzOi8vd3d3Lm1vbmV5bGlmZS5pbi9hcnRpY2xlL25pZnR5LXNlbnNleC1tYXktdHJ5LXRvLXJpc2UtYnV0LXRoZS10cmVuZC1pcy1kb3duLXdlZWtseS1jbG9zaW5nLXJlcG9ydC83MjQxMy5odG1s0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-27
16,Non-alcoholic Steatohepatitis Market to grow by USD 11.22 billion ...,PR Newswire,news.google.com/articles/CBMiyQFodHRwczovL3d3dy5wcm5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2VzL25vbi1hbGNvaG9saWMtc3RlYXRvaGVwYXRpdGlzLW1hcmtldC10by1ncm93LWJ5LXVzZC0xMS0yMi1iaWxsaW9uLS1mcm9tLTIwMjItdG8tMjAyNy0tbm9ydGgtYW1lcmljYS10by1hY2NvdW50LWZvci01MS1vZi1tYXJrZXQtZ3Jvd3RoLS10ZWNobmF2aW8tMzAxOTY5NjU4Lmh0bWzSAQA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-27
9,Dr. Reddy's Laboratories outperforms competitors despite losses on the day,MarketWatch,news.google.com/articles/CBMigQFodHRwczovL3d3dy5tYXJrZXR3YXRjaC5jb20vc3RvcnkvZHItcmVkZHktcy1sYWJvcmF0b3JpZXMtb3V0cGVyZm9ybXMtY29tcGV0aXRvcnMtZGVzcGl0ZS1sb3NzZXMtb24tdGhlLWRheS0zYjAxMDdhNi1jMDM1NWI0ODM2MjXSAYkBaHR0cHM6Ly93d3cubWFya2V0d2F0Y2guY29tL2FtcC9kYXRhLW5ld3MvZHItcmVkZHktcy1sYWJvcmF0b3JpZXMtb3V0cGVyZm9ybXMtY29tcGV0aXRvcnMtZGVzcGl0ZS1sb3NzZXMtb24tdGhlLWRheS0zYjAxMDdhNi1jMDM1NWI0ODM2MjU?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-27
15,Infibeam Group buys Sintex corporate house from NBFC,Times of India,news.google.com/articles/CBMigQFodHRwczovL3RpbWVzb2ZpbmRpYS5pbmRpYXRpbWVzLmNvbS9jaXR5L2FobWVkYWJhZC9pbmZpYmVhbS1ncm91cC1idXlzLXNpbnRleC1jb3Jwb3JhdGUtaG91c2UtZnJvbS1uYmZjL2FydGljbGVzaG93LzEwNDcxMTA3My5jbXPSAYUBaHR0cHM6Ly90aW1lc29maW5kaWEuaW5kaWF0aW1lcy5jb20vY2l0eS9haG1lZGFiYWQvaW5maWJlYW0tZ3JvdXAtYnV5cy1zaW50ZXgtY29ycG9yYXRlLWhvdXNlLWZyb20tbmJmYy9hbXBfYXJ0aWNsZXNob3cvMTA0NzExMDczLmNtcw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-26
1,Zydus Lifesciences begins Phase II trial of novel drug to treat fatal motor neuron disease,The Financial Express,news.google.com/articles/CBMioQFodHRwczovL3d3dy5maW5hbmNpYWxleHByZXNzLmNvbS9oZWFsdGhjYXJlL3BoYXJtYS1oZWFsdGhjYXJlL3p5ZHVzLWxpZmVzY2llbmNlcy1iZWdpbnMtcGhhc2UtaWktdHJpYWwtb2Ytbm92ZWwtZHJ1Zy10by10cmVhdC1mYXRhbC1tb3Rvci1uZXVyb24tZGlzZWFzZS8zMjg2NTgwL9IBpgFodHRwczovL3d3dy5maW5hbmNpYWxleHByZXNzLmNvbS9oZWFsdGhjYXJlL3BoYXJtYS1oZWFsdGhjYXJlL3p5ZHVzLWxpZmVzY2llbmNlcy1iZWdpbnMtcGhhc2UtaWktdHJpYWwtb2Ytbm92ZWwtZHJ1Zy10by10cmVhdC1mYXRhbC1tb3Rvci1uZXVyb24tZGlzZWFzZS8zMjg2NTgwL2xpdGUv?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-26
27,Foreign Investment Prospects in India's Pharmaceutical Industry,India Briefing,news.google.com/articles/CBMibmh0dHBzOi8vd3d3LmluZGlhLWJyaWVmaW5nLmNvbS9uZXdzL2ZvcmVpZ24taW52ZXN0bWVudC1wcm9zcGVjdHMtaW4taW5kaWFzLXBoYXJtYWNldXRpY2FsLWluZHVzdHJ5LTI5OTM4Lmh0bWwv0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-26
26,"Share Market Highlights 25 October 2023: Sensex tanks 522 pts, Nifty around 19126; Tata Steel, Coal India shine, Apollo, Adani drag",BusinessLine,news.google.com/articles/CBMiaGh0dHBzOi8vd3d3LnRoZWhpbmR1YnVzaW5lc3NsaW5lLmNvbS9tYXJrZXRzL3N0b2NrLW1hcmtldC1oaWdobGlnaHRzLTI1LW9jdG9iZXItMjAyMy9hcnRpY2xlNjc0NTYyODYuZWNl0gFtaHR0cHM6Ly93d3cudGhlaGluZHVidXNpbmVzc2xpbmUuY29tL21hcmtldHMvc3RvY2stbWFya2V0LWhpZ2hsaWdodHMtMjUtb2N0b2Jlci0yMDIzL2FydGljbGU2NzQ1NjI4Ni5lY2UvYW1wLw?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-25
21,Global Motion Sickness Drugs Market Set to Grow by $136.49 ...,GlobeNewswire,news.google.com/articles/CBMiuAFodHRwczovL3d3dy5nbG9iZW5ld3N3aXJlLmNvbS9uZXdzLXJlbGVhc2UvMjAyMy8xMC8yNS8yNzY2NDE5LzI4MTI0L2VuL0dsb2JhbC1Nb3Rpb24tU2lja25lc3MtRHJ1Z3MtTWFya2V0LVNldC10by1Hcm93LWJ5LTEzNi00OS1NaWxsaW9uLWJ5LTIwMjctRnVlbGVkLWJ5LU92ZXItdGhlLUNvdW50ZXItT3B0aW9ucy5odG1s0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-25
0,"Zydus Lifesciences launches trial for sclerosis treatment, shares up",BusinessLine,news.google.com/articles/CBMihAFodHRwczovL3d3dy50aGVoaW5kdWJ1c2luZXNzbGluZS5jb20vbWFya2V0cy96eWR1cy1saWZlc2NpZW5jZXMtbGF1bmNoZXMtdHJpYWwtZm9yLXNjbGVyb3Npcy10cmVhdG1lbnQtc2hhcmVzLXVwL2FydGljbGU2NzQ1NjU2OS5lY2XSAYkBaHR0cHM6Ly93d3cudGhlaGluZHVidXNpbmVzc2xpbmUuY29tL21hcmtldHMvenlkdXMtbGlmZXNjaWVuY2VzLWxhdW5jaGVzLXRyaWFsLWZvci1zY2xlcm9zaXMtdHJlYXRtZW50LXNoYXJlcy11cC9hcnRpY2xlNjc0NTY1NjkuZWNlL2FtcC8?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-25
2,"Zydus Lifesciences initiates Phase II clinical trial of ZYIL1, a novel ...",PipelineReview.com,news.google.com/articles/CBMi4gFodHRwczovL3BpcGVsaW5lcmV2aWV3LmNvbS9pbmRleC5waHAvMjAyMzEwMjU4NDU2Ny9TbWFsbC1Nb2xlY3VsZXMvWnlkdXMtTGlmZXNjaWVuY2VzLWluaXRpYXRlcy1QaGFzZS1JSS1jbGluaWNhbC10cmlhbC1vZi1aWUlMMS1hLW5vdmVsLW9yYWwtTkxSUDMtaW5mbGFtbWFzb21lLWluaGliaXRvci1pbi1wYXRpZW50cy13aXRoLUFteW90cm9waGljLUxhdGVyYWwtU2NsZXJvc2lzLUFMUy5odG1s0gEA?hl=en-IN&gl=IN&ceid=IN%3Aen,2023-10-25
